237 related articles for article (PubMed ID: 3131041)
1. Antianginal effects of intravenous nitroglycerin over 24 hours.
Zimrin D; Reichek N; Bogin KT; Aurigemma G; Douglas P; Berko B; Fung HL
Circulation; 1988 Jun; 77(6):1376-84. PubMed ID: 3131041
[TBL] [Abstract][Full Text] [Related]
2. [Sustained effect of nitroglycerin ointment on exercise tolerance in patients with effort angina (author's transl)].
Previtali M; Salerno JA; Falcone C; Lepore R; Chimienti M; Medici A; Angoli L; Bobba P
G Ital Cardiol; 1980; 10(5):584-91. PubMed ID: 6778754
[TBL] [Abstract][Full Text] [Related]
3. Nitroglycerin in chronic stable angina pectoris.
Reichek N
Am J Cardiol; 1987 Nov; 60(15):15H-17H. PubMed ID: 3120561
[TBL] [Abstract][Full Text] [Related]
4. Antianginal effects of nitroglycerin patches.
Reichek N; Priest C; Zimrin D; Chandler T; Sutton MS
Am J Cardiol; 1984 Jul; 54(1):1-7. PubMed ID: 6430053
[TBL] [Abstract][Full Text] [Related]
5. Effects of a transdermal patch system containing nitroglycerin on exercise tolerance in patients with angina pectoris. Double-blind, placebo controlled, comparison with slow-release nifedipine and verapamil.
Gibelli G; Negrini M; Mazzocchi F; Prina L; Pollavini P; De Ponti C
G Ital Cardiol; 1986 Nov; 16(11):904-8. PubMed ID: 3104124
[TBL] [Abstract][Full Text] [Related]
6. Failure of transdermal nitroglycerin to improve chronic stable angina: a randomized, placebo-controlled, double-blind, double crossover trial.
Crean PA; Ribeiro P; Crea F; Davies GJ; Ratcliffe D; Maseri A
Am Heart J; 1984 Dec; 108(6):1494-500. PubMed ID: 6439019
[TBL] [Abstract][Full Text] [Related]
7. Increased exercise tolerance after nitroglycerin oral spray: a new and effective therapeutic modality in angina pectoris.
Kimchi A; Lee G; Amsterdam E; Fujii K; Krieg P; Mason DT
Circulation; 1983 Jan; 67(1):124-7. PubMed ID: 6401172
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of oral nitroglycerin in the therapy of exertion angina].
Ceci V; Longo A; Franchetti-Pardo N; Di Mario F; Milazzotto F; Biffani G
G Ital Cardiol; 1985 Sep; 15(9):888-896. PubMed ID: 3936739
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of a new transdermal nitroglycerin patch (Deponit 10) for stable angina pectoris.
Greco R; D'Alterio D; Schiattarella M; Boccia A; Greco L; Marsico F
Am J Cardiol; 1988 Mar; 61(9):44E-51E. PubMed ID: 3126635
[TBL] [Abstract][Full Text] [Related]
10. Sustained high-dose nitroglycerin transcutaneous patch therapy in angina pectoris: evidence for attenuation of effect over time.
Frishman WH; Giles T; Greenberg S; Heiman M; Raffidal L; Soberman J; Laifer L; Nadelmann J; Lazar E; Strom J
J Clin Pharmacol; 1989 Dec; 29(12):1097-105. PubMed ID: 2515215
[TBL] [Abstract][Full Text] [Related]
11. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
Rezaković DE; Lakatos S; Stalec J; Pavicić L
Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
[TBL] [Abstract][Full Text] [Related]
12. Safety of intravenous nitroglycerin after administration of sildenafil citrate to men with coronary artery disease: a double-blind, placebo-controlled, randomized, crossover trial.
Parker JD; Bart BA; Webb DJ; Koren MJ; Siegel RL; Wang H; Malhotra B; Jen F; Glue P
Crit Care Med; 2007 Aug; 35(8):1863-8. PubMed ID: 17522570
[TBL] [Abstract][Full Text] [Related]
13. [Interval therapy in effective treatment of angina pectoris using nitroglycerin patch systems. A controlled study with determination of nitroglycerin plasma levels].
Reiniger G; Menke G; Boertz A; Kraus F; Rudolph W
Herz; 1987 Feb; 12(1):68-73. PubMed ID: 3104180
[TBL] [Abstract][Full Text] [Related]
14. N-acetylcysteine attenuates nitroglycerin tolerance in patients with angina pectoris and normal left ventricular function.
Pizzulli L; Hagendorff A; Zirbes M; Jung W; Lüderitz B
Am J Cardiol; 1997 Jan; 79(1):28-33. PubMed ID: 9024731
[TBL] [Abstract][Full Text] [Related]
15. [Development of tolerance in continuous nitroglycerin infusion].
Niestegge H; Cordes G; Blümchen G
Herz; 1989 Feb; 14(1):66-70. PubMed ID: 2493413
[TBL] [Abstract][Full Text] [Related]
16. Determination of the optimal dose of glyceryl trinitrate in the treatment of stable angina.
Mannering D; Kemp AL; Bennett ED
Eur Heart J; 1987 Jul; 8(7):744-7. PubMed ID: 3115779
[TBL] [Abstract][Full Text] [Related]
17. The effects on exercise tolerance of a new transdermal therapeutic system containing nitroglycerine, in patients with stable angina pectoris.
Carù B; Pirelli S; Ferratini M; Gasparini M; Cattafi G; Corrada E; Pollavini P
Eur Heart J; 1988 Jan; 9 Suppl A():105-11. PubMed ID: 3137062
[TBL] [Abstract][Full Text] [Related]
18. [Anti-angina and coronary dilating effect of low-dose nitroglycerin].
Sievert H; Kober G; Schneider W; Kaltenbach M; Bussmann WD
Z Kardiol; 1989; 78 Suppl 2():48-51; discussion 64-7. PubMed ID: 2511693
[TBL] [Abstract][Full Text] [Related]
19. Exercise capacity with transdermal nitroglycerin in patients with stable angina pectoris.
Naafs MA; de Boer AC; Koster RW; Klazen CW; Dunning AJ
Eur Heart J; 1984 Sep; 5(9):705-9. PubMed ID: 6437815
[TBL] [Abstract][Full Text] [Related]
20. Influence of captopril on nitroglycerin-mediated vasodilation and development of nitrate tolerance in arterial and venous circulation.
Pizzulli L; Hagendorff A; Zirbes M; Fehske W; Ewig S; Jung W; Lüderitz B
Am Heart J; 1996 Feb; 131(2):342-9. PubMed ID: 8579031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
